Publicacións nas que colabora con Susana Belén Bravo López (23)

2024

  1. Characterization of the plasma proteomic profile of Fabry disease: Potential sex- and clinical phenotype-specific biomarkers

    Translational Research, Vol. 269, pp. 47-63

  2. Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

    Nature Communications

  3. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

    Nature Communications

  4. Morquio A Syndrome: Identification of Differential Patterns of Molecular Pathway Interactions in Bone Lesions

    International Journal of Molecular Sciences, Vol. 25, Núm. 6

  5. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Identification of Proteomic Biomarkers in Proliferative Verrucous Leukoplakia through Liquid Chromatography With Tandem Mass Spectrometry

    Laboratory investigation; a journal of technical methods and pathology, Vol. 103, Núm. 10, pp. 100222

2022

  1. Proteomics in Inherited Metabolic Disorders

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

2021

  1. Characterization of new proteomic biomarker candidates in mucopolysaccharidosis type IVA

    International Journal of Molecular Sciences, Vol. 22, Núm. 1, pp. 1-22

  2. Plasma proteomic analysis in morquio a disease

    International Journal of Molecular Sciences, Vol. 22, Núm. 11

  3. Protein Extraction From FFPE Kidney Tissue Samples: A Review of the Literature and Characterization of Techniques

    Frontiers in Medicine, Vol. 8

2020

  1. A novel nanoproteomic approach for the identification of molecular targets associated with thyroid tumors

    Nanomaterials, Vol. 10, Núm. 12, pp. 1-20

2019

  1. Proteomic Analysis in Morquio A Cells Treated with Immobilized Enzymatic Replacement Therapy on Nanostructured Lipid Systems

    International journal of molecular sciences, Vol. 20, Núm. 18

2017

  1. Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer

    Oncogene, Vol. 36, Núm. 5, pp. 652-666

2016

  1. FNDC5 is produced in the stomach and associated to body composition

    Scientific Reports, Vol. 6

2013

  1. Humanized medium (h7H) allows long-term primary follicular thyroid cultures from human normal thyroid, benign neoplasm, and cancer

    Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 6, pp. 2431-2441

2012

  1. Aplicación de proteómica a la búsqueda de nuevos mecanismos tumorales en cáncer de tiroides

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 8, pp. 114-114

2010

  1. Expression of exogenous proteins and short hairpin RNAs in human primary thyrocytes

    Analytical Biochemistry, Vol. 400, Núm. 2, pp. 219-228

  2. Identification of a paired box gene 8-peroxisome proliferator-activated receptor gamma (PAX8-PPARγ) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH receptor

    Endocrine-Related Cancer, Vol. 17, Núm. 3, pp. 599-610

  3. New insights into thyroglobulin pathophysiology revealed by the study of a family with congenital goiter

    Journal of Clinical Endocrinology and Metabolism, Vol. 95, Núm. 7, pp. 3522-3526

2008

  1. Ghrelin localization in the medulla of rat and human adrenal gland and in pheochromocytomas

    Histology and Histopathology, Vol. 23, Núm. 1, pp. 57-65